98 related articles for article (PubMed ID: 21054681)
1. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease.
Botta-Orfila T; Ezquerra M; Ríos J; Fernández-Santiago R; Cervantes S; Samaranch L; Pastor P; Martí MJ; Muñoz E; Valldeoriola F; Aguilar M; Calopa M; Hernández-Vara J; Tolosa E
Eur J Neurol; 2011 Mar; 18(3):e32. PubMed ID: 21054681
[No Abstract] [Full Text] [Related]
2. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
3. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
Huang Y; Rowe DB; Halliday GM
J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
[TBL] [Abstract][Full Text] [Related]
4. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
5. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
[TBL] [Abstract][Full Text] [Related]
6. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
[TBL] [Abstract][Full Text] [Related]
8. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
9. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
10. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
11. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.
Goris A; Williams-Gray CH; Clark GR; Foltynie T; Lewis SJ; Brown J; Ban M; Spillantini MG; Compston A; Burn DJ; Chinnery PF; Barker RA; Sawcer SJ
Ann Neurol; 2007 Aug; 62(2):145-53. PubMed ID: 17683088
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain.
Fuchs J; Tichopad A; Golub Y; Munz M; Schweitzer KJ; Wolf B; Berg D; Mueller JC; Gasser T
FASEB J; 2008 May; 22(5):1327-34. PubMed ID: 18162487
[TBL] [Abstract][Full Text] [Related]
13. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease.
Deng H; Xie W; Guo Y; Le W; Jankovic J
Mov Disord; 2006 May; 21(5):728-9. PubMed ID: 16552756
[No Abstract] [Full Text] [Related]
14. Parkinson's disease correlates with promoter methylation in the α-synuclein gene.
Pihlstrøm L; Berge V; Rengmark A; Toft M
Mov Disord; 2015 Apr; 30(4):577-80. PubMed ID: 25545759
[TBL] [Abstract][Full Text] [Related]
15. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
[TBL] [Abstract][Full Text] [Related]
16. SNP rs7684318 of the alpha-synuclein gene is associated with Parkinson's disease in the Han Chinese population.
Yu L; Xu P; He X; Hu F; Lin Z; Zhu M; Liu Z; He L; Xu Y
Brain Res; 2010 Jul; 1346():262-5. PubMed ID: 20513365
[TBL] [Abstract][Full Text] [Related]
17. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
[TBL] [Abstract][Full Text] [Related]
18. SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
Emelyanov A; Andoskin P; Yakimovskii A; Usenko T; Nuzhnyi E; Nikolaev M; Pchelina S
Parkinsonism Relat Disord; 2013 Nov; 19(11):1064-5. PubMed ID: 23830801
[No Abstract] [Full Text] [Related]
19. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
[TBL] [Abstract][Full Text] [Related]
20. Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning.
Kéri S; Nagy H; Myers CE; Benedek G; Shohamy D; Gluck MA
Genes Brain Behav; 2008 Feb; 7(1):31-6. PubMed ID: 17451452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
